112 related articles for article (PubMed ID: 10073977)
1. Effects of gamma-tocotrienol on ApoB synthesis, degradation, and secretion in HepG2 cells.
Theriault A; Wang Q; Gapor A; Adeli K
Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):704-12. PubMed ID: 10073977
[TBL] [Abstract][Full Text] [Related]
2. Effects of tocotrienol on the intracellular translocation and degradation of apolipoprotein B: possible involvement of a proteasome independent pathway.
Wang Q; Theriault A; Gapor A; Adeli K
Biochem Biophys Res Commun; 1998 May; 246(3):640-3. PubMed ID: 9618265
[TBL] [Abstract][Full Text] [Related]
3. Effects of atorvastatin on the intracellular stability and secretion of apolipoprotein B in HepG2 cells.
Mohammadi A; Macri J; Newton R; Romain T; Dulay D; Adeli K
Arterioscler Thromb Vasc Biol; 1998 May; 18(5):783-93. PubMed ID: 9598838
[TBL] [Abstract][Full Text] [Related]
4. Modulation of hepatic lipoprotein synthesis and secretion by taxifolin, a plant flavonoid.
Theriault A; Wang Q; Van Iderstine SC; Chen B; Franke AA; Adeli K
J Lipid Res; 2000 Dec; 41(12):1969-79. PubMed ID: 11108730
[TBL] [Abstract][Full Text] [Related]
5. Intracellular mechanisms mediating the inhibition of apoB-containing lipoprotein synthesis and secretion in HepG2 cells by avasimibe (CI-1011), a novel acyl-coenzyme A: cholesterol acyltransferase (ACAT) inhibitor.
Taghibiglou C; Van Iderstine SC; Kulinski A; Rudy D; Adeli K
Biochem Pharmacol; 2002 Feb; 63(3):349-60. PubMed ID: 11853686
[TBL] [Abstract][Full Text] [Related]
6. Insulin modulation of hepatic synthesis and secretion of apolipoprotein B by rat hepatocytes.
Sparks JD; Sparks CE
J Biol Chem; 1990 May; 265(15):8854-62. PubMed ID: 2187873
[TBL] [Abstract][Full Text] [Related]
7. Effects of dexamethasone on the synthesis, degradation, and secretion of apolipoprotein B in cultured rat hepatocytes.
Wang CN; McLeod RS; Yao Z; Brindley DN
Arterioscler Thromb Vasc Biol; 1995 Sep; 15(9):1481-91. PubMed ID: 7670964
[TBL] [Abstract][Full Text] [Related]
8. Regulated intracellular degradation of apolipoprotein B in semipermeable HepG2 cells.
Adeli K
J Biol Chem; 1994 Mar; 269(12):9166-75. PubMed ID: 8132654
[TBL] [Abstract][Full Text] [Related]
9. A two-site model for ApoB degradation in HepG2 cells.
Wu X; Sakata N; Lele KM; Zhou M; Jiang H; Ginsberg HN
J Biol Chem; 1997 Apr; 272(17):11575-80. PubMed ID: 9111073
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of hepatocyte apoB secretion by naringenin: enhanced rapid intracellular degradation independent of reduced microsomal cholesteryl esters.
Borradaile NM; de Dreu LE; Barrett PH; Huff MW
J Lipid Res; 2002 Sep; 43(9):1544-54. PubMed ID: 12235187
[TBL] [Abstract][Full Text] [Related]
11. Cotranslational inhibition of apoB-100 synthesis by cyclosporin A in the human hepatoma cell line HepG2.
Kaptein A; de Wit EC; Princen HM
Arterioscler Thromb; 1994 May; 14(5):780-9. PubMed ID: 8172854
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein B is both integrated into and translocated across the endoplasmic reticulum membrane. Evidence for two functionally distinct pools.
Davis RA; Thrift RN; Wu CC; Howell KE
J Biol Chem; 1990 Jun; 265(17):10005-11. PubMed ID: 2161829
[TBL] [Abstract][Full Text] [Related]
13. In HepG2 cells, translocation, not degradation, determines the fate of the de novo synthesized apolipoprotein B.
Bonnardel JA; Davis RA
J Biol Chem; 1995 Dec; 270(48):28892-6. PubMed ID: 7499417
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of HMG-CoA reductase by atorvastatin decreases both VLDL and LDL apolipoprotein B production in miniature pigs.
Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2589-600. PubMed ID: 9409231
[TBL] [Abstract][Full Text] [Related]
15. The molecular mechanism for the assembly and secretion of ApoB-100-containing lipoproteins.
Borén J; White A; Wettesten M; Scott J; Graham L; Olofsson SO
Prog Lipid Res; 1991; 30(2-3):205-18. PubMed ID: 1823939
[TBL] [Abstract][Full Text] [Related]
16. Studies on intracellular translocation of apolipoprotein B in a permeabilized HepG2 system.
Macri J; Adeli K
J Biol Chem; 1997 Mar; 272(11):7328-37. PubMed ID: 9054431
[TBL] [Abstract][Full Text] [Related]
17. Studies of the sites of intracellular degradation of apolipoprotein B in Hep G2 cells.
Furukawa S; Sakata N; Ginsberg HN; Dixon JL
J Biol Chem; 1992 Nov; 267(31):22630-8. PubMed ID: 1429611
[TBL] [Abstract][Full Text] [Related]
18. The assembly and secretion of ApoB 100-containing lipoproteins in Hep G2 cells. ApoB 100 is cotranslationally integrated into lipoproteins.
Borén J; Graham L; Wettesten M; Scott J; White A; Olofsson SO
J Biol Chem; 1992 May; 267(14):9858-67. PubMed ID: 1315773
[TBL] [Abstract][Full Text] [Related]
19. ApoB100 secretion from HepG2 cells is decreased by the ACAT inhibitor CI-1011: an effect associated with enhanced intracellular degradation of ApoB.
Wilcox LJ; Barrett PH; Newton RS; Huff MW
Arterioscler Thromb Vasc Biol; 1999 Apr; 19(4):939-49. PubMed ID: 10195921
[TBL] [Abstract][Full Text] [Related]
20. Proteasome-mediated degradation of apolipoprotein B targets both nascent peptides cotranslationally before translocation and full-length apolipoprotein B after translocation into the endoplasmic reticulum.
Liao W; Yeung SC; Chan L
J Biol Chem; 1998 Oct; 273(42):27225-30. PubMed ID: 9765244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]